Q1 2019 Vitrolife AB Earnings Call Transcript
Good morning, ladies and gentlemen, thank you for standing by, and welcome to the Vitrolife Interim Report January to March 2019 (Operator Instructions) I'd now like -- I must advise you, sorry, the conference is being recorded today, Tuesday, the 23rd of April 2019.
I would now like to hand the conference over to your first speaker today, Thomas Axelsson. Please, go ahead.
()-
Thank you very much, and welcome to Vitrolife Interim Report January-March 2019. The speakers today will be Mikael Engblom, CFO of Vitrolife; and myself, Thomas Axelsson, the CEO of Vitrolife.
So please go to page number 2 and we'll go through the summary of Q1. The Q1, for us, was a quarter with continuous high profitability and I would also like to comment that we had a new business unit for this quarter. So sales was SEK 312 million and it's a growth of 18%. The sales increase was 12% in local currency, where 4% was organic growth. EBITDA 40% margin and totaled SEK 126 million.
During
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |